Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2017

Open Access 01-12-2017 | Research

Quality measurers of therapeutic communities for substance dependence: an international collaborative study survey in Latin America

Authors: Carlos Gómez-Restrepo, Patricia Maldonado, Nelcy Rodríguez, Rafael Ruiz-Gaviria, Miguel Ángel Escalante, Raúl Ángel Gómez, Marcelo Ribeiro de Araujo, Ana Carolina Schmidt de Oliveira, Joel Salvador Chávez Rivera, Jorge Alberto Godínez García, Marina Piazza Ferrand, Dora Blitchtein-Winicki

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2017

Login to get access

Abstract

Background

In Latin America, substance related disorders are highly prevalent and one of the treatment strategies is the Therapeutic Communities (TCs), however, in Latin America there is scarce data about this treatment strategies, their quality, drop-out rates and patient satisfaction.

Methods

Based on a previous study in 5 Latin American countries, the TCs who had a score equal or higher than 9 according to the De Leon criteria which are some fundamental items that the TCs should meet, were selected to carry out a descriptive and retrospective study of qualitative and quantitative characteristics of the TCs.

Results

Data from 58 TCs in 5 countries were included, with a sample of 1414 patients interviewed, of which most were single men, with no hospitalization history in a therapeutic community. Marijuana was the most commonly substance used in the 30 days prior to hospitalization, with 78% of interviewees referring alcohol consumption in the last 6 months and an average onset of psychoactive substances at 16 years of age. A 79% of the patients interviewed perceived some improvement during their stay in the TCs. The less fulfilled Quality Indicators by the TCs were “Requesting a professional qualification to former addicts that belonged to the program” and “Work as part of the therapeutic program”. Among the reasons for discharge found in the database, 44% were due to therapeutic discharge with fulfillment of the treatment plan and 44% withdraws.

Conclusion

The user satisfaction with TCs, in terms of infrastructure and quality are quite high, as the fulfillment of essential quality items, however, the follow up information to evaluate effectiveness of the treatment is poor or in some cases unknown.
Literature
1.
go back to reference Caulkins JPPD, Kasunic AMS, Lee MACMS. Societal burden of substance abuse. Int. Public Health J. 2014;6:269–82. Caulkins JPPD, Kasunic AMS, Lee MACMS. Societal burden of substance abuse. Int. Public Health J. 2014;6:269–82.
2.
go back to reference Observatorio argentino de drogas. Estudio de costos del abuso de sustancias psicoactivas en la Argentina. Argentina: Buenos Aires; 2007. Observatorio argentino de drogas. Estudio de costos del abuso de sustancias psicoactivas en la Argentina. Argentina: Buenos Aires; 2007.
3.
go back to reference Observatorio peruano de drogas. Estudio del impacto social y económico del consumo de drogas en el Perú. Lima. In: Perú; 2010. Observatorio peruano de drogas. Estudio del impacto social y económico del consumo de drogas en el Perú. Lima. In: Perú; 2010.
5.
go back to reference Ferrando SJ, Freyberg Z. Neuropsychiatric aspects of infectious diseases. Crit Care Clin. 2008;24:889–919. xCrossRefPubMed Ferrando SJ, Freyberg Z. Neuropsychiatric aspects of infectious diseases. Crit Care Clin. 2008;24:889–919. xCrossRefPubMed
7.
go back to reference WHO International Consortium. In psychiatric epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders. Bull World Health Organ. 2000;78:413–26. WHO International Consortium. In psychiatric epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders. Bull World Health Organ. 2000;78:413–26.
8.
go back to reference Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet. 2013;382:1575–86.CrossRefPubMed Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the global burden of disease study 2010. Lancet. 2013;382:1575–86.CrossRefPubMed
10.
go back to reference De Leon G, editor. Community as method: therapeutic communities for special populations and special settings. Westport, Conn: Praeger; 1997. De Leon G, editor. Community as method: therapeutic communities for special populations and special settings. Westport, Conn: Praeger; 1997.
12.
go back to reference Smith LA, Gates S, Foxcroft D. Therapeutic communities for substance related disorder. Cochrane Database Syst Rev. 2006:CD005338. Smith LA, Gates S, Foxcroft D. Therapeutic communities for substance related disorder. Cochrane Database Syst Rev. 2006:CD005338.
13.
go back to reference Johnson K, Pan Z, Young L, Vanderhoff J, Shamblen S, Browne T, et al. Therapeutic community drug treatment success in Peru: a follow-up outcome study. Subst Abuse Treat Prev Policy. 2008;3:26.CrossRefPubMedPubMedCentral Johnson K, Pan Z, Young L, Vanderhoff J, Shamblen S, Browne T, et al. Therapeutic community drug treatment success in Peru: a follow-up outcome study. Subst Abuse Treat Prev Policy. 2008;3:26.CrossRefPubMedPubMedCentral
14.
go back to reference Fiestas F, Ponce J. Eficacia de las comunidades terapéuticas en el tratamiento de problemas por uso de sustancias psicoactivas: una revisión sistemática. Rev. perú. med. exp. salud. Publica. 2012;29:12–20. Fiestas F, Ponce J. Eficacia de las comunidades terapéuticas en el tratamiento de problemas por uso de sustancias psicoactivas: una revisión sistemática. Rev. perú. med. exp. salud. Publica. 2012;29:12–20.
15.
go back to reference Vanderplasschen W, Colpaert K, Autrique M, Rapp RC, Pearce S, Broekaert E, et al. Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective. ScientificWorldJournal. 2013;2013:427817.PubMedPubMedCentral Vanderplasschen W, Colpaert K, Autrique M, Rapp RC, Pearce S, Broekaert E, et al. Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective. ScientificWorldJournal. 2013;2013:427817.PubMedPubMedCentral
16.
go back to reference Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abus Treat. 2003;25:125–34.CrossRef Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abus Treat. 2003;25:125–34.CrossRef
17.
go back to reference Goethals I, Soyez V, Melnick G, De Leon G, Broekaert E. Essential elements of treatment: a comparative study between European and American therapeutic communities for addiction. Subst. Use Misuse. 2011;46:1023–31.CrossRefPubMed Goethals I, Soyez V, Melnick G, De Leon G, Broekaert E. Essential elements of treatment: a comparative study between European and American therapeutic communities for addiction. Subst. Use Misuse. 2011;46:1023–31.CrossRefPubMed
18.
go back to reference De Leon G. Therapeutic communities for addictions: a theoretical framework. Int J Addict. 1995;30:1603–45.CrossRefPubMed De Leon G. Therapeutic communities for addictions: a theoretical framework. Int J Addict. 1995;30:1603–45.CrossRefPubMed
19.
go back to reference De Leon G. The therapeutic community: theory, model, and method. New York: Springer Pub; 2000. De Leon G. The therapeutic community: theory, model, and method. New York: Springer Pub; 2000.
21.
go back to reference Johnson KW, Young L, Shamblen S, Suresh G, Browne T, Chookhare KW. Evaluation of the therapeutic community treatment model in Thailand: policy implications for compulsory and prison-based treatment. Subst Use Misuse. 2012;47:889–909.CrossRefPubMed Johnson KW, Young L, Shamblen S, Suresh G, Browne T, Chookhare KW. Evaluation of the therapeutic community treatment model in Thailand: policy implications for compulsory and prison-based treatment. Subst Use Misuse. 2012;47:889–909.CrossRefPubMed
22.
go back to reference Fernández-Montalvo J, López-Goñi JJ, Illescas C, Landa N, Lorea I. Evaluation of a therapeutic community treatment program: a long-term follow-up study in Spain. Subst. Use Misuse. 2008;43:1362–77.CrossRefPubMed Fernández-Montalvo J, López-Goñi JJ, Illescas C, Landa N, Lorea I. Evaluation of a therapeutic community treatment program: a long-term follow-up study in Spain. Subst. Use Misuse. 2008;43:1362–77.CrossRefPubMed
23.
go back to reference Sadir N, Shojaei M, Moadab K, Abbasi R, Bahrampour A, Nakhaee N. Outcome evaluation of therapeutic community model in iran. Int J Health Policy Manag. 2013;1:131–5.CrossRefPubMedPubMedCentral Sadir N, Shojaei M, Moadab K, Abbasi R, Bahrampour A, Nakhaee N. Outcome evaluation of therapeutic community model in iran. Int J Health Policy Manag. 2013;1:131–5.CrossRefPubMedPubMedCentral
24.
go back to reference Darke S, Campbell G, Popple G. Retention, early dropout and treatment completion among therapeutic community admissions. Drug Alcohol Rev. 2012;31:64–71.CrossRefPubMed Darke S, Campbell G, Popple G. Retention, early dropout and treatment completion among therapeutic community admissions. Drug Alcohol Rev. 2012;31:64–71.CrossRefPubMed
25.
go back to reference Ministerio de Justicia y del Derecho - Observatorio de Drogas de Colombia, Ministerio, de Salud y Protección Social. Estudio Nacional de Consumo de Sustancias Psicoactivas en Colombia 2013- Informe Final. Bogotá. Colombia: ALVI Impresores S.A.S; 2014. Ministerio de Justicia y del Derecho - Observatorio de Drogas de Colombia, Ministerio, de Salud y Protección Social. Estudio Nacional de Consumo de Sustancias Psicoactivas en Colombia 2013- Informe Final. Bogotá. Colombia: ALVI Impresores S.A.S; 2014.
26.
go back to reference López-Goñi JJ, Fernández-Montalvo J, Illescas C, Landa N, Lorea I. Razones para el abandono del tratamiento en una comunidad terapéutica. Trastor Adict. 2008;10:104–11.CrossRef López-Goñi JJ, Fernández-Montalvo J, Illescas C, Landa N, Lorea I. Razones para el abandono del tratamiento en una comunidad terapéutica. Trastor Adict. 2008;10:104–11.CrossRef
27.
go back to reference Melnick G, De Leon G. Clarifying the nature of therapeutic community treatment. The survey of essential elements questionnaire (SEEQ). J Subst Abus Treat. 1999;16:307–13.CrossRef Melnick G, De Leon G. Clarifying the nature of therapeutic community treatment. The survey of essential elements questionnaire (SEEQ). J Subst Abus Treat. 1999;16:307–13.CrossRef
Metadata
Title
Quality measurers of therapeutic communities for substance dependence: an international collaborative study survey in Latin America
Authors
Carlos Gómez-Restrepo
Patricia Maldonado
Nelcy Rodríguez
Rafael Ruiz-Gaviria
Miguel Ángel Escalante
Raúl Ángel Gómez
Marcelo Ribeiro de Araujo
Ana Carolina Schmidt de Oliveira
Joel Salvador Chávez Rivera
Jorge Alberto Godínez García
Marina Piazza Ferrand
Dora Blitchtein-Winicki
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2017
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/s13011-017-0129-y

Other articles of this Issue 1/2017

Substance Abuse Treatment, Prevention, and Policy 1/2017 Go to the issue